betamethasone-17,21-dipropionate has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Legaz Martínez, M; Magdaleno-Tapial, J; Martínez-Doménech, Á; Pérez-Ferriols, A; Pérez-Pastor, G; Valenzuela-Oñate, C | 1 |
| Bradford, J; Chin, S; Fischer, G; Lee, G; Scurry, J | 1 |
2 other study(ies) available for betamethasone-17,21-dipropionate and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Digital ulcerative lichenoid dermatitis in a patient receiving anti-PD-1 therapy.
Topics: Administration, Cutaneous; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Betamethasone; Carcinoma, Squamous Cell; Drug Combinations; Gentamicins; Humans; Lichenoid Eruptions; Male; Mouth Neoplasms; Programmed Cell Death 1 Receptor; Skin; Skin Ulcer | 2019 |
Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Carcinoma in Situ; Carcinoma, Squamous Cell; Clobetasol; Desonide; Female; Humans; Hydrocortisone; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Vulvar Lichen Sclerosus; Vulvar Neoplasms | 2020 |